InsidersTradesSigma
Follow the 영진약품 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 영진약품 has published 1 reports. Market capitalisation: €209.8bn. The latest transaction was reported on 12 March 2026 (Other). Among the most active insiders: 영진약품. Every trade is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
영진약품 是一家医疗保健和制药领域的公司，在 XKRX 市场上市。它专注于药品的研发和制造。